Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Absorption by oral, dermal or inhalative route is considered low (10%) and bioaccumulation potential is also low.

Key value for chemical safety assessment

Bioaccumulation potential:
low bioaccumulation potential
Absorption rate - oral (%):
10
Absorption rate - dermal (%):
10
Absorption rate - inhalation (%):
10

Additional information

FAT41029/A is expected to be absorbed in humans via different routes - oral (assumed 10%), dermal (assumed 10%) and inhalation route (assumed 10% only if humans are exposed to dust) due to the physico-chemical properties (i.e. high molecular weight, low water solubility, small fraction of particles reaching the thoracic area). Following absorption via oral, inhalative or dermal route, FAT41029/A is anticipated to be distributed to liver and eventually also to kidneys. Excretion is expected via urine or feces, and as a conclusion FAT 41029/A has a low accumulation potential in the human body.